CagriSema (Cagrilintide + Semaglutide) 10mg

Description

CagriSema (Cagrilintide + Semaglutide) 10mg — Research-Grade Peptide (≥99% Purity)

CagriSema (Cagrilintide + Semaglutide) is a blend of the amylin analogue cagrilintide with semaglutide. It is supplied by
Alluvia as a high-purity reference peptide for laboratory
and research applications, and is studied in research relating to dual-action fullness and appetite loss.

Mechanism of Action in Research

In published and preclinical research, CagriSema (Cagrilintide + Semaglutide) combines GLP-1 appetite reduction with amylin satiety for amplified, complementary weight loss.
Alluvia supplies every batch at ≥99% purity, verified by independent HPLC
and mass-spectrometry testing so researchers know exactly what they are working
with.

Areas of Research Interest

CagriSema (Cagrilintide + Semaglutide) has been investigated by researchers in connection with:

• Two complementary appetite pathways
• Stronger fullness and craving control
• Supports greater weight loss
• A premium combination peptide

Research-Grade Quality from Alluvia (Australia)

• ≥99% purity — independently lab-tested with a downloadable Certificate of Analysis
• Australian-based dispatch with fast, tracked shipping
• Cold-chain handling and stable storage for full potency on arrival
• Responsive local support and secure checkout

Important — Research Use Only

CagriSema (Cagrilintide + Semaglutide) is sold for laboratory and research use only. It
is intended exclusively for in-vitro experimentation and scientific study by
qualified researchers. It is not for human or animal consumption
and is not a drug, food, cosmetic or dietary supplement. By purchasing, you
confirm you are a qualified researcher or institution and accept full
responsibility for safe, lawful handling and disposal.

Frequently Asked Questions

What is CagriSema (Cagrilintide + Semaglutide)?

CagriSema (Cagrilintide + Semaglutide) is a blend of the amylin analogue cagrilintide with semaglutide. In the laboratory it is studied in research relating to dual-action fullness and appetite loss. In research models, CagriSema (Cagrilintide + Semaglutide) combines GLP-1 appetite reduction with amylin satiety for amplified, complementary weight loss.

Is CagriSema (Cagrilintide + Semaglutide) for human use?

No. CagriSema (Cagrilintide + Semaglutide) is supplied strictly as a research chemical for in-vitro and laboratory study. It is not a medicine, supplement, cosmetic or food, and is not for human or animal consumption.

How should CagriSema (Cagrilintide + Semaglutide) be stored and handled?

Store lyophilised CagriSema (Cagrilintide + Semaglutide) frozen and away from light. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and handle using appropriate laboratory safety practices.

Does CagriSema (Cagrilintide + Semaglutide) ship within Australia?

Yes. Alluvia dispatches CagriSema (Cagrilintide + Semaglutide) 10mg Australia-wide, with a Certificate of Analysis confirming ≥99% purity for every batch.